101 related articles for article (PubMed ID: 9699184)
1. A small proline-rich protein, spr1: specific marker for squamous lung carcinoma.
Hu R; Wu R; Deng J; Lau D
Lung Cancer; 1998 Apr; 20(1):25-30. PubMed ID: 9699184
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis.
Lau D; Xue L; Hu R; Liaw T; Wu R; Reddy S
Am J Respir Cell Mol Biol; 2000 Jan; 22(1):92-6. PubMed ID: 10615070
[TBL] [Abstract][Full Text] [Related]
3. Loss of spr1 expression measurable by quantitative RT-PCR in human bronchogenic carcinoma cell lines.
DeMuth JP; Weaver DA; Crawford EL; Jackson CM; Willey JC
Am J Respir Cell Mol Biol; 1998 Jul; 19(1):25-9. PubMed ID: 9651177
[TBL] [Abstract][Full Text] [Related]
4. Expression, regulation, and function of the SPR family of proteins. A review.
Tesfaigzi J; Carlson DM
Cell Biochem Biophys; 1999; 30(2):243-65. PubMed ID: 10356644
[TBL] [Abstract][Full Text] [Related]
5. SPR1. An early molecular marker for bronchial carcinogenesis.
Lau D; Guo L; Chan A; Wu R
Methods Mol Med; 2003; 75():397-403. PubMed ID: 12407755
[No Abstract] [Full Text] [Related]
6. Cell cycle-specific expression of G(0)SPR1 in Chinese hamster ovary cells.
Tesfaigzi J; Carlson DM
Exp Cell Res; 1996 Nov; 228(2):277-82. PubMed ID: 8912721
[TBL] [Abstract][Full Text] [Related]
7. Expression of a squamous cell marker, the spr1 gene, is posttranscriptionally down-regulated by retinol in airway epithelium.
An G; Tesfaigzi J; Carlson DM; Wu R
J Cell Physiol; 1993 Dec; 157(3):562-8. PubMed ID: 8253868
[TBL] [Abstract][Full Text] [Related]
8. Sequence and expression patterns of mouse SPR1: Correlation of expression with epithelial function.
Kartasova T; Darwiche N; Kohno Y; Koizumi H; Osada S; Huh N; Lichti U; Steinert PM; Kuroki T
J Invest Dermatol; 1996 Feb; 106(2):294-304. PubMed ID: 8601731
[TBL] [Abstract][Full Text] [Related]
9. An unusual expression of a squamous cell marker, small proline-rich protein gene, in tracheobronchial epithelium: differential regulation and gene mapping.
An G; Huang TH; Tesfaigzi J; Garcia-Heras J; Ledbetter DH; Carlson DM; Wu R
Am J Respir Cell Mol Biol; 1992 Jul; 7(1):104-11. PubMed ID: 1627333
[TBL] [Abstract][Full Text] [Related]
10. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
12. Bronchogenic squamous cell carcinomas with invasion along alveolar walls.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Histopathology; 1996 Oct; 29(4):363-8. PubMed ID: 8910044
[TBL] [Abstract][Full Text] [Related]
13. Basement membranes in bronchogenic squamous cell carcinoma: an immunohistochemical and ultrastructural study.
Havenith MG; Dingemans KP; Cleutjens JP; Wagenaar SS; Bosman FT
Ultrastruct Pathol; 1990; 14(1):51-63. PubMed ID: 2296803
[TBL] [Abstract][Full Text] [Related]
14. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
15. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Agackiran Y; Ozcan A; Akyurek N; Memis L; Findik G; Kaya S
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):350-5. PubMed ID: 22495379
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
Sueoka E; Sueoka N; Goto Y; Matsuyama S; Nishimura H; Sato M; Fujimura S; Chiba H; Fujiki H
Cancer Res; 2001 Mar; 61(5):1896-902. PubMed ID: 11280744
[TBL] [Abstract][Full Text] [Related]
17. WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.
Zhang Y; Hu C
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
[TBL] [Abstract][Full Text] [Related]
18. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
19. Neuronatin expression and its clinicopathological significance in pulmonary non-small cell carcinoma.
Uchihara T; Okubo C; Tanaka R; Minami Y; Inadome Y; Iijima T; Morishita Y; Fujita J; Noguchi M
J Thorac Oncol; 2007 Sep; 2(9):796-801. PubMed ID: 17805055
[TBL] [Abstract][Full Text] [Related]
20. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
